{
  "id": "pulmonary_embolism_criteria",
  "type": "diagnostic_criteria",
  "name": "Pulmonary Embolism - Diagnosis and Risk Stratification",
  "content": "PULMONARY EMBOLISM (PE):\n\nDEFINITION:\n- Obstruction of pulmonary artery or branches by thrombus (usually from DVT)\n\nCLINICAL PRESENTATION:\n- Dyspnea (most common, 73%)\n- Pleuritic chest pain (44%)\n- Cough (34%), hemoptysis (13%)\n- Tachypnea >20/min (54%)\n- Tachycardia >100 bpm (24%)\n- Signs of DVT (15%)\n\nPRE-TEST PROBABILITY - Wells Score:\n- Clinical signs DVT (3 points)\n- PE most likely diagnosis (3)\n- HR >100 (1.5)\n- Immobilization ≥3 days or surgery within 4 weeks (1.5)\n- Prior PE/DVT (1.5)\n- Hemoptysis (1)\n- Malignancy (1)\n\nInterpretation:\n- ≤4: PE unlikely (use D-dimer)\n- >4: PE likely (proceed to imaging)\n\nPESI (Pulmonary Embolism Severity Index):\n- Age, male sex, cancer, HF, COPD, HR, SBP, RR, temp, O2 sat, mental status\n- Class I-II: Low risk (mortality <3%)\n- Class III-V: High risk (mortality 3-25%)\n\nDIAGNOSTIC WORKUP:\n\n1. D-DIMER:\n   - High sensitivity, low specificity\n   - <500 ng/mL rules out PE if low pre-test probability\n   - Age-adjusted: Age × 10 for patients >50 years\n   - Limited use if high pre-test probability, hospitalized, cancer, pregnant\n\n2. CT PULMONARY ANGIOGRAPHY (CTPA):\n   - Gold standard for diagnosis\n   - Sensitivity 83%, specificity 96%\n   - Direct visualization of clot\n\n3. V/Q SCAN:\n   - Alternative if contrast contraindicated\n   - High probability scan diagnostic\n   - Normal scan rules out PE\n\n4. ADDITIONAL TESTS:\n   - Lower extremity ultrasound (if DVT suspected)\n   - ECG: Sinus tachycardia, S1Q3T3 pattern (20%)\n   - ABG: Hypoxemia, respiratory alkalosis\n   - Troponin, BNP (prognostic)\n   - Echocardiogram (assess RV strain)\n\nRISK STRATIFICATION:\n\nMassive PE (High-risk):\n- Sustained hypotension (SBP <90 or drop ≥40mmHg >15min)\n- Cardiogenic shock, cardiac arrest\n- Mortality 25-50%\n\nSubmassive PE (Intermediate-risk):\n- Hemodynamically stable\n- RV dysfunction (echo or CT) OR troponin elevation\n- Mortality 3-15%\n\nLow-risk PE:\n- Hemodynamically stable\n- No RV dysfunction or troponin elevation\n- PESI class I-II\n- Mortality <1%, consider outpatient treatment\n\nTREATMENT:\n\n1. ANTICOAGULATION (All patients):\n   \n   Initial:\n   - LMWH (enoxaparin 1 mg/kg SC q12h or 1.5 mg/kg daily)\n   - Unfractionated heparin (if renal insufficiency, high bleeding risk)\n   - Fondaparinux\n   \n   Long-term:\n   - DOACs preferred: Rivaroxaban, apixaban, edoxaban, dabigatran\n   - Warfarin (target INR 2-3) if DOAC contraindicated\n   - Duration:\n     * Provoked (surgery, trauma): 3 months\n     * Unprovoked: 3-6 months (consider extended if low bleeding risk)\n     * Cancer-associated: 3-6 months (prefer LMWH or DOAC)\n     * Recurrent: Indefinite\n\n2. THROMBOLYSIS (Massive PE):\n   - tPA 100mg IV over 2 hours\n   - Contraindications: Active bleeding, recent surgery, ICH, ischemic stroke <3mo\n\n3. CATHETER-DIRECTED THERAPY:\n   - Consider if massive PE with contraindication to systemic lysis\n   - Or submassive PE with deterioration\n\n4. SURGICAL EMBOLECTOMY:\n   - Rescue therapy if thrombolysis fails or contraindicated\n\n5. IVC FILTER:\n   - Only if absolute contraindication to anticoagulation\n   - Prefer retrievable filters\n\n6. SUPPORTIVE:\n   - Oxygen to maintain SpO2 >90%\n   - Fluid resuscitation (caution: avoid overload in RV failure)\n   - Vasopressors if shock (norepinephrine)\n\nPROGNOSIS:\n- Overall mortality: 10-30% (if untreated)\n- 2-3% (if treated)\n- Recurrence risk: 5-10% at 1 year if unprovoked",
  "metadata": {
    "category": "cardiovascular",
    "diagnosis": "pulmonary_embolism",
    "priority": "CRITICAL",
    "source": "ESC PE Guidelines 2019, CHEST Guidelines"
  }
}
